Listed on GrantGunner. Last checked 16 Sep 2026.
About this grant
Base Launch partners with scientists and entrepreneurs to help build biopharma ventures from scratch, offering non-dilutive funding of up to CHF 500,000 as a convertible loan, industry access, expert knowledge, and infrastructure. Selected startups receive guidance on company creation, IP, indication strategy, and business development, along with access to global pharma networks and lab infrastructure where needed.
Who can apply
Breakthrough innovations that can form the basis of new biopharma ventures, from all over the world. Projects at any stage from pre-seed to seed, including those with only a Post Doc or Professor. Therapeutic products or platform projects (all modalities and disease areas). Not for medtech, diagnostics, digital health, or therapeutic service offers without product development intent.